Prader-Willi syndrome (PWS) is an imprinted neurodevelopmental disease caused by a loss of paternal genes on chromosome 15q11-q13. It is characterized by cognitive impairments, developmental delay, sleep abnormalities, and hyperphagia often leading to obesity. Clinical research has shown that a lack of expression of SNORD116, a paternally expressed imprinted gene cluster that encodes multiple copies of a small nucleolar RNA (snoRNA) in both humans and mice, is most likely responsible for many PWS symptoms seen in humans. The majority of previous research using PWS preclinical models focused on characterization of the hyperphagic and metabolic phenotypes. However, a crucial understudied clinical phenotype is cognitive impairments and thus we investigated the learning and memory abilities using a model of PWS, with a heterozygous deletion in Snord116. We utilized the novel object recognition task, which doesn't require external motivation, or exhaustive swim training. Automated findings were further confirmed with manual scoring by a highly trained blinded investigator. We discovered deficits in Snord116+/− mutant mice in the novel object recognition, location memory and tone cue fear conditioning assays when compared to age-, sex-matched, littermate control Snord116+/+ mice. Further, we confirmed that despite physical neo-natal developmental delays, Snord116+/ − mice had normal exploratory and motor abilities. These results show that the Snord116+/− deletion murine model is a valuable preclinical model for investigating learning and memory impairments in individuals with PWS without common confounding phenotypes.
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Introduction
Prader-Willi syndrome (PWS) is a rare genetic disorder that occurs in approximately 1:15,000 live births. PWS is characterized by neonatal failure to thrive, developmental delay, lack of satiety cues, lack of control of food intake and metabolic abnormalities that lead to obesity. In addition to obesity, PWS affected individuals usually exhibit low to moderate intellectual disability and issues with numerous tasks related to executive function (e.g., response inhibition, set-shifting and planning) (Dykens, Hodapp, Walsh, & Nash, 1992a , 1992b Dykens, Leckman, & Cassidy, 1996; Dykens et al., 2017; Dykens and Shah, 2003; Martin et al., 1998; Schwartz et al., 2016) .
Due to the imprinted status of the 15q11-q13 locus, allele-specific mutations lead to the development of two distinct neurodevelopmental disorders. PWS results from genetic mutations leading to deficient gene expression from the paternal allele of chromosome 15 (15q11-q13), while Angelman Syndrome (AS) results from mutations inherited from the maternal allele of the same locus, emphasizing a critical neurological function of these genes (Jiang, Tsai, Bressler, & Beaudet, 1998) . Numerous mutant mouse models were generated by targeting different portions of the orthologous mouse region. The first model deleted the entire PWS/AS locus, similar to the vast majority of PWS and/or AS patients (Gabriel et al., 1999; Stefan, Portis, Longnecker, & Nicholls, 2005) . Follow-up model systems highlighted the PWS imprinting center and informed the essential nature of the epigenetic processes (Yang et al., 1998) . Several smaller deletion and single gene mutant model systems have been created to delineate the contribution of each gene in the region to aspects of the PWS phenotype. These include models deleting exons in the small nuclear ribonucleoprotein polypeptide N (Snrpn), an RNA-protein complex that forms an RNA spliceosome (Bressler et al., 2001; Dubose, Smith, Yang, Johnstone, & Resnick, 2011; Tsai, Jiang, et al., 1999) 
